Suppr超能文献

细胞与组织重编程:开启药物研发的新时代。

Cell and tissue reprogramming: Unlocking a new era in medical drug discovery.

作者信息

Sen Chandan K, Friday Andrew J, Roy Sashwati

机构信息

McGowan Institute for Regenerative Medicine and Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania.

McGowan Institute for Regenerative Medicine and Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania.

出版信息

Pharmacol Rev. 2025 Jun 26;77(5):100077. doi: 10.1016/j.pharmr.2025.100077.

Abstract

Recent advancements in cell and tissue biology have fundamentally changed our understanding of cellular behavior, revealing that both stem and nonstem cells exhibit remarkable plasticity and adaptability. This discovery has paved the way for revolutionary medical drug therapies that leverage cell and tissue reprogramming to repair or regenerate damaged tissues, offering new hope for conditions that were once considered irreversible. Tissue reprogramming involves the activation of specific molecular pathways to convert the function of residual tissue to compensate for the loss of tissue function to aging, trauma, or disease processes. By targeting these pathways, emerging drugs can promote regenerative processes, enabling the restoration of tissue function lost due to aging, injury, or disease. These therapies have shown promising results in preclinical studies addressing a wide range of diseases. Unlike traditional treatments, which focus primarily on managing symptoms, tissue reprogramming therapies offer a dynamic approach that can fundamentally alter cellular states, leading to functional recovery. This review explores the current state of cell and tissue reprogramming, highlighting its potential applications in regenerative medicine and the challenges that must be addressed for successful clinical translation. As our understanding of cellular plasticity continues to evolve, these innovative therapies stand at the forefront of a new era in medicine, with the potential to transform treatment paradigms and significantly improve patient outcomes across a wide range of conditions. SIGNIFICANCE STATEMENT: Breakthrough technologies have transformed our understanding of cell and tissue biology, uncovering that cells and tissues possess remarkable adaptability and fluidity in their roles. This revelation has opened up exciting possibilities in regenerative medicine, where emerging drug therapies aim to harness and reprogram cells to repair or regenerate damaged tissues. An emerging class of medical drugs will activate the body's natural regenerative abilities, offering the potential to restore tissue function lost due to aging, injury, or disease.

摘要

细胞与组织生物学的最新进展从根本上改变了我们对细胞行为的理解,揭示出干细胞和非干细胞均展现出显著的可塑性和适应性。这一发现为革命性的药物疗法铺平了道路,这些疗法利用细胞和组织重编程来修复或再生受损组织,为曾经被认为不可逆转的病症带来了新希望。组织重编程涉及激活特定分子途径,以转变残余组织的功能,从而补偿因衰老、创伤或疾病过程导致的组织功能丧失。通过靶向这些途径,新兴药物能够促进再生过程,恢复因衰老、损伤或疾病而丧失的组织功能。这些疗法在针对多种疾病的临床前研究中已显示出有前景的结果。与主要侧重于控制症状的传统治疗方法不同,组织重编程疗法提供了一种动态方法,可从根本上改变细胞状态,从而实现功能恢复。本综述探讨了细胞和组织重编程的当前状况,强调了其在再生医学中的潜在应用以及成功临床转化必须解决的挑战。随着我们对细胞可塑性的理解不断发展,这些创新疗法处于医学新时代的前沿,有可能改变治疗模式,并在广泛病症中显著改善患者预后。重要声明:突破性技术改变了我们对细胞和组织生物学的理解,揭示出细胞和组织在其功能方面具有显著的适应性和流动性。这一发现为再生医学带来了令人兴奋的可能性,新兴药物疗法旨在利用并重新编程细胞以修复或再生受损组织。一类新兴的药物将激活人体的自然再生能力,有可能恢复因衰老、损伤或疾病而丧失的组织功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c9e/12359172/e47e13c9e404/nihms-2101107-f0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验